These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 30602447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
    Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F, Mantel I.
    Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
    [Abstract] [Full Text] [Related]

  • 3. OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy.
    Borrelli E, Battista M, Sacconi R, Gelormini F, Querques L, Grosso D, Vella G, Bandello F, Querques G.
    Am J Ophthalmol; 2021 Mar; 223():129-139. PubMed ID: 33342759
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy.
    Liu T, Lin W, Zhou S, Meng X.
    Br J Ophthalmol; 2021 Feb; 105(2):233-238. PubMed ID: 32265200
    [Abstract] [Full Text] [Related]

  • 7. Optical coherence tomography angiography findings in fellow eyes of choroidal neovascularisation associated with central serous chorioretinopathy.
    Mandadi SKR, Singh SR, Sahoo NK, Mishra SB, Sacconi R, Iovino C, Berger L, Munk MR, Querques G, Peiretti E, Chhablani J.
    Br J Ophthalmol; 2021 Sep; 105(9):1280-1285. PubMed ID: 30798261
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F, Schütze C, Burgmüller M, Vécsei-Marlovits PV, Weingessel B.
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY, Chung H, Kim HC.
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [Abstract] [Full Text] [Related]

  • 11. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J, Pichi F, Silva R, Casella AM, Murthy H, Banker A, Nowilaty SR, Carrai P, Nucci P, Arevalo JF, King Khaled Eye Specialist Hospital International Collaborative Retina Study Group.
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
    Dhurandhar DS, Singh SR, Sahoo NK, Goud A, Lupidi M, Chhablani J.
    Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
    [Abstract] [Full Text] [Related]

  • 14. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
    Hwang H, Kim JY, Kim KT, Chae JB, Kim DY.
    Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity.
    Erol MK, Ozdemir O, Coban DT, Ceran BB, Bulut M.
    Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW, Chin AT, de Carlo T, Klein KA, Baumal CR, Witkin AJ, Duker JS, Waheed NK.
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study.
    Sacconi R, Tomasso L, Corbelli E, Carnevali A, Querques L, Casati S, Bandello F, Querques G.
    Eye (Lond); 2019 Nov; 33(11):1809-1817. PubMed ID: 31267094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.